| Application no. and date | 20736424.1 (espacenet) (Federated) (European Patent Register), 20200605 | | Patent/reg. no. and date | DK/EP 3980434, 20231004 | | Publication date | 20220413 | | Priority no. and date | IT 201900008391, 20190607 | | EP pub. no. and date |
EP 3980434 20220413 | | Effective date | | | Applicant/owner | Abiogen Pharma S.p.A., Via Meucci 36 - Loc. Ospedaletto
56121 Pisa, IT | | Applicant ref. no. | V468292DK00 | | Inventor | NEGGIANI, Fabio, Via Randaccio, 12
56123 Pisa, IT,
CHIARUCCI, Michel, Via Villanova, 2/3
40055 CASTENASO, IT,
FABBRONI, Serena, Via San Vitale Est, 139
40059 MEDICINA, IT,
GIAFFREDA, Stefano Luca, Via Camillo Benso Conte di Cavour 94/A
40026 IMOLA, IT,
POLITI, Barbara, Via Baracca, 27
57128 Livorno, IT | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C07F 9/38 (2006.01) | | Title | Fremgangsmåde til fremstilling af polymorph af natriumneridronat | | Int. application no. | IB2020055304 | | Int. publication no. | WO2020245780 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
